Gene Biotherapeutics Inc (CRXM):企業の財務・戦略的SWOT分析

◆英語タイトル:Gene Biotherapeutics Inc (CRXM) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME422FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Gene Biotherapeutics Inc (CRXM) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Gene Biotherapeutics Inc (Gene Biotherapeutics), formerly Taxus Cardium Pharmaceuticals Group Inc, is a development stage company with focus on regenerative medicine. It develops manufacturing process and technology platforms for cardiovascular disease, wound healing and tissue engineering based on its core gene therapy. Its product portfolio includes Generx used for the treatment of cardiac microvascular insufficiency, refractory angina, cardiac syndrome X, congestive heart failure, moyamoya diseases and cerebral ischemia. It markets its products through third party commercialization partners. Gene Biotherapeutics is headquartered in San Diego, California, the US.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Gene Biotherapeutics Inc – Key Facts
Gene Biotherapeutics Inc – Key Employees
Gene Biotherapeutics Inc – Key Employee Biographies
Gene Biotherapeutics Inc – Major Products and Services
Gene Biotherapeutics Inc – History
Gene Biotherapeutics Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Gene Biotherapeutics Inc – Business Description
Gene Biotherapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Gene Biotherapeutics Inc – Strengths
Gene Biotherapeutics Inc – Weaknesses
Gene Biotherapeutics Inc – Opportunities
Gene Biotherapeutics Inc – Threats
Gene Biotherapeutics Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Gene Biotherapeutics Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Gene Biotherapeutics Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Gene Biotherapeutics Inc, Recent Deals Summary
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Gene Biotherapeutics Inc, Key Facts
Gene Biotherapeutics Inc, Key Employees
Gene Biotherapeutics Inc, Key Employee Biographies
Gene Biotherapeutics Inc, Major Products and Services
Gene Biotherapeutics Inc, History
Gene Biotherapeutics Inc, Subsidiaries
Gene Biotherapeutics Inc, Key Competitors
Gene Biotherapeutics Inc, Ratios based on current share price
Gene Biotherapeutics Inc, Annual Ratios
Gene Biotherapeutics Inc, Annual Ratios (Cont...1)
Gene Biotherapeutics Inc, Interim Ratios
Gene Biotherapeutics Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Gene Biotherapeutics Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Gene Biotherapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Gene Biotherapeutics Inc (CRXM):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PPG Industries, Inc.:企業のM&A・事業提携・投資動向
    PPG Industries, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's PPG Industries, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Cape plc:企業の戦略・SWOT・財務分析
    Cape plc - Strategy, SWOT and Corporate Finance Report Summary Cape plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Selecta Biosciences Inc (SELB):企業の財務・戦略的SWOT分析
    Summary Selecta Biosciences Inc (Selecta Biosciences) is a biopharmaceutical company that develops immunotherapies and vaccines for the treatment and prevention of human diseases. The company’s pipeline products include SEL-212, SEL-403, SEL-302 and SEL-302. It utilizes synthetic vaccine particle (S …
  • Care Group:企業の製品パイプライン分析2018
    Summary Care Group India (Care Group) is a manufacturer and supplier of intraocular lens (IOLs) and ophthalmic surgical products. Its product portfolio includes cataract intraocular lens (IOLs) including hydrophilic, hydrophobic, polymethyl methacrylate (PMMA) models and implantable phakic contact l …
  • Getlink SE (GET):企業の財務・戦略的SWOT分析
    Getlink SE (GET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • GE Healthcare:企業のM&A・事業提携・投資動向
    GE Healthcare - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's GE Healthcare Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Western & Southern Financial Group, Inc.:戦略・SWOT・企業財務分析
    Western & Southern Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Western & Southern Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Amey Plc:企業の戦略的SWOT分析
    Amey Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • H.I.S. Co., Ltd.:企業の戦略・SWOT・財務情報
    H.I.S. Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary H.I.S. Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Development Bank of Japan Inc:企業の戦略・SWOT・財務情報
    Development Bank of Japan Inc - Strategy, SWOT and Corporate Finance Report Summary Development Bank of Japan Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Sareum Holdings Plc (SAR)-製薬・医療分野:企業M&A・提携分析
    Summary Sareum Holdings Plc (Sareum) is a drug discovery and development company that produces targeted small molecule therapeutics for treating cancer and autoimmune diseases. The drug research programs of the company are based on its proprietary drug discovery technology, SKIL (Sareum Kinase Inhib …
  • Xcel Energy Inc:発電所・企業SWOT分析
    Xcel Energy Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (ex …
  • Ontario Municipal Employees Retirement System:電力:M&Aディール及び事業提携情報
    Summary Ontario Municipal Employees Retirement System (OMERS) offers pension benefits to government employees, beneficiaries, and retirees from diverse sectors such as municipalities, libraries, police and fire departments, schools, and other agencies in Ontario. It is sponsored by OMERS Sponsors Co …
  • Clinical Laserthermia Systems AB (CLS B):企業の財務・戦略的SWOT分析
    Clinical Laserthermia Systems AB (CLS B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Ocado Group Plc:企業の戦略・SWOT・財務情報
    Ocado Group Plc - Strategy, SWOT and Corporate Finance Report Summary Ocado Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • PerkinElmer, Inc.:企業の戦略・SWOT・財務情報
    PerkinElmer, Inc. - Strategy, SWOT and Corporate Finance Report Summary PerkinElmer, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Lexmark International Inc:企業の戦略的SWOT分析
    Lexmark International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Hays plc (HAS):企業の財務・戦略的SWOT分析
    Hays plc (HAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • MakeMyTrip Limited:企業の戦略・SWOT・財務分析
    MakeMyTrip Limited - Strategy, SWOT and Corporate Finance Report Summary MakeMyTrip Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Mitteldeutsche Braunkohlengesellschaft mbH:企業の戦略的SWOT分析
    Mitteldeutsche Braunkohlengesellschaft mbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆